Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Molecules (Basel, Switzerland)|September 23, 2022
Dosimetry of [<sup>212</sup>Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free <sup>208</sup>Tl on Tissue Absorbed DosesKelly D Orcutt, Kelly E Henry, Christine Habjan, et al.
Pharmaceutics|February 25, 2023
Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based TheranosticsMengshi Li, Nicholas J Baumhover, Dijie Liu, et al.
Plos One|December 30, 2020
Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogelKyle C Kloepping, Alora S Kraus, Devin K Hedlund, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 16, 2007
A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United StatesMichael K Schultz, Jeffrey T Cessna, Tamara L Anderson, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand TherapyMengshi Li, Claudia Robles-Planells, Dijie Liu, et al.
Radiation Research|July 3, 2025
Targeting CXCR4 with 212Pb/203Pb-Pentixather Significantly Increases Overall Survival in Small Cell Lung CancerKeegan A Christensen, Melissa A Fath, Jordan T Ewald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2023
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapyMengshi Li, Claudia Robles-Planells, Dijie Liu, et al.
Free Radical Biology & Medicine|February 8, 2020
Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copperKelly C Falls-Hubert, Aimee L Butler, Kai Gui, et al.
Cancer Cell|April 4, 2017
O<sub>2</sub><sup>⋅-</sup> and H<sub>2</sub>O<sub>2</sub>-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateJoshua D Schoenfeld, Zita A Sibenaller, Kranti A Mapuskar, et al.
Pageof 6